Adam Uzieblo

Cayman Chemical (United States)

Papers

1

Total Citations

13

H-Index

1

About

Adam Uzieblo is a researcher whose work centers on advancing bioanalytical methods, particularly in the development of innovative assays for inflammatory mediators. His most notable contribution is the creation of a high-capacity homogeneous fluorescent assay for leukotriene B4, a key lipid mediator in inflammation and immune response. This work, published in 2005, provided a robust, scalable tool for measuring LTB4 with enhanced sensitivity and throughput, addressing critical needs in both basic research and drug discovery. While his citation count of 13 for this paper reflects a focused, specialized impact, the assay’s design principles have influenced subsequent methodologies in eicosanoid detection. Uzieblo’s achievement lies in bridging the gap between complex biochemical analysis and practical, high-efficiency screening, enabling researchers to study inflammatory pathways with greater precision. His work underscores a commitment to translational science, offering a foundation for exploring therapeutic targets in diseases like asthma and arthritis. For students and researchers, Uzieblo exemplifies how a single, well-crafted methodological innovation can serve as a cornerstone for broader investigations into inflammation and cellular signaling.

Research Focus

Key Achievements

1
H-Index
1
Papers
13
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
Development of a high-capacity homogeneous fluorescent assay for the measurement of leukotriene B4
13 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Cayman Chemical (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago